chrisvoncsefalvay/vaers-outcomes huggingface dataset:
approx. 12 hours after receiving Flu shot  at work  I began having chills.  The chills became stronger, took my temperature orally and had low grade temp of 100.2.  Fever peaked out  at 103.0 for 4 to 5 hours.    Had moderate headache with fever and  moderate generalized weakness.    No other symptoms were present.   Symptoms  lasted approx.  36 hours
-I started nothing my lunge feeling infected and feeling winded after a routine walk with my dogs - very lightheaded for weeks - feeling a tight throat  - itchiness around my neck, shoulders and arms - small tire mark kind of rashes or dots or quarter sized rashes that come and go on neck arms back and shoulders. - shortness of breath... couldn?t take satisfying breaths  I still have all these symptoms to this day... my doctor gave me an inhaler. I thought it was an STD but my gynecologist told me she?s never known for my stds to be related to my lungs.  - made an appointment to see a pulmonologist
For the next 2 days I had a fever, headache, fatigue, I just wanted to sleep. It is 4/3/21 and I am just now getting back to myself. I took 2 extra strength Tylenol every 6 hours for the fever. I was also pretty thirsty which I don?t end up being when I?m sick.
A report was received from a health professional on 12/3/03 concerning a 6 month old male vaccinee who was inadvertently administered Fluvirin on 12/2/03. On 12/3/03, the vaccinee inadvertently received 0.25ml of Fluvirin. No adverse effects were reported at time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Mom advised physician that pt broke out in hives approximately 45 minutes to one hour after receiving vax.
Swelling and rash on arm after 7 days of vaccine dose; Swelling and rash on arm after 7 days of vaccine dose; Injection site welts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling and rash on arm after 7 days of vaccine dose), VACCINATION SITE URTICARIA (Injection site welts) and VACCINATION SITE RASH (Swelling and rash on arm after 7 days of vaccine dose) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022BUA) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2021, the patient experienced VACCINATION SITE SWELLING (Swelling and rash on arm after 7 days of vaccine dose) and VACCINATION SITE URTICARIA (Injection site welts). On an unknown date, the patient experienced VACCINATION SITE RASH (Swelling and rash on arm after 7 days of vaccine dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Swelling and rash on arm after 7 days of vaccine dose), VACCINATION SITE URTICARIA (Injection site welts) and VACCINATION SITE RASH (Swelling and rash on arm after 7 days of vaccine dose) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant Medication Was provided.
BP shot up to 197/130; Throbbing headache; Nausea; Tingling in both arms and fingers; Itchy tongue; Iitching all over body; Clamminess; Fatigue; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 52-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EP6955), via an unspecified route of administration, administered in left arm on 18Mar2021, 15:30 (age at vaccination was 52-year-old) as single dose for covid-19 immunization at hospital. Medical history included hypertension. The patient concomitant medication included Hydrochlorothiazide. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnose with COVID-19. The patient had not been tested for COVID-19 since the vaccination. The patient had no known allergies to medications, food, or other products. On 18Mar2021 at 15:45 Within 60 seconds of vaccine, I got an immediate throbbing headache, nausea, tingling in both arms and fingers, itchy tongue, itching all over body, BP shot up to 197/130, clamminess, and fatigue. Patient received a treatment with Antihistamine given during episode for the events. The patient underwent lab test and procedures which included blood pressure measurement: 197/130 on unspecified date in Mar2021. The outcome of the events was not recovered.  Additional information is excepted. Follow up is requested.
pt. was red from the back of her neck all the way down, and the around the injection its red, hard, itching
Symptoms: red, warm, tender, raised/firm, itchy spot at site of injection bigger than a quarter.; Started approx. 6 days post vaccine Treatment: Ice and benadryl Outcome: pending
Information has been received from a physician a female who was vaccinated with GARDASIL. Subsequently the patient experienced erythma, multiforme. Therapy with human papillomavirus vaccine was discontinued. The patient sought unspecified medical attention and her out come was unknown. Additional information has been requested.
I was admitted to ER with stroke  and  right arm weakness.  While I was in the ER, I also developed unconsciously seizure. The diagnosis are Cerebral Venous Thrombosis (CVT, multiple clots) and Cerebral Venous  Sinus Thrombosis (CVST), Focal motor seizure and Cerebral Edema.
Reoccurring fever, even after taking Motrin. Went to urgent care for chest pain (stabbing pain in chest, and painful to breathe). My EKG and oxygen levels were all fine, they told me to follow up with my primary doctor.
Could not eat or drink; Mouth swelled up; Lips swelled up; Tongue swelled up; Fuzziness in her eye right after.; Severe pain in her mouth; A spontaneous report was received from a consumer, concerning a 72 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events mouth swelled up/mouth swelling, lip swelled up/lip swelling, tongue swelled up/swollen tongue, experienced some fuzziness in her eyes/vision blurred, severe pain in her mouth/oral pain, could not eat or drink/dysphagia, swollen mouth got worse.  The patient's past medical history included rashes due to medication allergy. Products known to have been used by the patient, within two weeks prior to the event were not reported.  On 07 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 031L20A) intramuscularly on left armfor prophylaxis of COVID-19 infection.  On 07 Feb 2021 after vaccination, the patient experienced fuzziness in right eye. Later that evening, the developed swollen mouth, lips ad tongue. The patient had severe pain in her mouth and subsequently consulted healthcare provider who recommended diphenhydramine, but it didn't work. On 09 Feb 2021, the patient swollen mouth got worse and was taken to emergency room. The patient was prescribed with solu-medrol shot and prescribed prednisone for next 5 days. This is medically significant. The patient could not eat or drink/dysphagia.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, mouth swelled up/mouth swelling, lip swelled up/lip swelling, tongue swelled up/swollen tongue, experienced some fuzziness in her eyes/vision blurred, severe pain in her mouth/oral pain, could not eat or drink/dysphagia, swollen mouth got worse were unknown.; Reporter's Comments: This case concerns a 72 Y/O F with a serious unexpected event of oral pain, and nonserious unexpected dysphagia, mouth swelling, lip swelling, swollen tongue, and feeling abnormal.  Event onset the same day as first dose mRNA-1273. Treated with diphenhydramine, solu-medrol, and prednisone. Event outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
administered a dose diluted with saline water; administered a dose diluted with saline water; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA764A, expiry date 31-DEC-2023) for prophylaxis.   On 08-MAR-2023, the patient received Menveo. On 08-MAR-2023, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: administered a dose diluted with saline water) and inappropriate dose of vaccine administered (Verbatim: administered a dose diluted with saline water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 09-Mar-2023 The pharmacist called to inform that the patient inadvertently received a dose of Menveo diluted with saline water instead of with the approved diluent supplied.  The healthcare professional agreed to the follow up by the GSK team.  The reporter clarified that follow up could be via phone on Thursdays, since those days the healthcare professional would available in the facility. The patient inadvertently received a dose of Menveo diluted with saline water instead of with the approved diluent supplied, which led to wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered.
Received both doses of the Pfizer vaccine, one in September and the final in October. By January, I noticed constant ringing in my ears. I went to an ENT and the doctor said this tinnitus is most likely related to the vaccine. I have no hearing loss.
Strep throat; He is sick; Sore throat; This is a spontaneous report from a contactable consumer (patient).A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0185,Expiry date:Unknown), via an unspecified route of administration on an unspecified date as a 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter asked if he should still get the second dose of the Pfizer Covid-19 vaccine as he supposed to get the 2nd dose on 08Jun2021, but currently he had strep throat. The reporter stated that he was kind of sick and had sore throat. The reporter had provided only limited information over call. The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age. On an unknown date the unspecified patients were vaccinated with an unknown number of doses of GARDASIL (lot number not reported) and RECOMBIVAX HB (lot number not reported) that were improperly stored, 31.0 degrees F. for possibly 24 hours and from 31.5-35 degrees F. for 58 days, No adverse effect reported. It was unspecified if the patients had sought medical attention. Additional information has been requested.
had the shot before I got shingles/suspected Vaccination failure; I got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the shot before I got shingles/suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I got shingles). The outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 10-MAR-2023 This case was reported by a patient via interactive digital media. The reporter reported that he/she forgot to mention that he/she had the shot before got shingles This case was considered as suspected vaccination failure, since the details regarding vaccination schedule, time to onset for event and laboratory confirmation of shingles were not provided. The follow-up could not be possible as no contact details were available
PATIENT OBSERVED DOING A UNUSUAL MOVEMENT WHILE IN A SITTING POSITION. PT IS ABLE TO SIT ON HER OWN. FATHER OBSERVED FOR THE FIRST TIME THE MOVEMENT. PT IS SITTING AND SHE CONTRACTS AND MOVES HER SHOULDERS FORWARD AND HER HEAD DUCKS DOWN. PT IS NOT SHAKING. PARENTS DESCRIBE THE MOVEMENT AS A CONTRACTION. THE MOVEMENT IS BECOMING MORE FREQUENT. PT HAS HAD MORE THAN A DOZEN OF THESE MOVEMENTS IN THE LAST 20 MIN. She does not seem to be bothered by it.  Symptoms only occur while sitting; not with laying down or while being carried.  An episode was recorded on video.
SYMPTOMS: Immediately after receiving the shot, I had red blotches all over body, arms, chest, face, legs and  feet . My feet felt like they were burning up and my heart rate went up to 96 bpm this Lasted for about 1/2, drank a glass of water felt better. The  blotches, burning feet and heart rated continued on and off for it seemed like an hour, this lasted three days.
This spontaneous report as received from a physician concerning a male patient with unspecified age, pertinent medical history or drug reaction/allergies. Several moths ago, the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX with unspecified number of shots. No other co-suspects were reported. No concomitant medications were reported. The patient experienced pain at the injection site that "went up the arm and across to the other arm" several months ago. There was no treatment reported. The patient's outcome was unknown. The patient sought an unspecified medical attention. Additional information has been requested.
Began to itch, but very painful to touch. I reported it to the clinic, and they stated it was normal. Throughout the day and into the night, the hematoma grew to the size of an adult fist. I have circled the progress with photos. I also began having flu-like symptoms with headache and general aches. I have also run fever into the 101 range. The left arm is painful to move or lean onto. I have not sought medical attention due to the fact the clinic is closed, and the closest hospital is 75 miles away, and I can not afford a ER visit.
Approx 48 hours after receiving vaccination, I developed uncontrollable shaking for 30 mins. It felt like it was coming from the inside and working its way across my body. It tensed by abdomen and back muscles so tightly the pain was excruciating . jaw and limbs were also tremoring.  I'm a super fit person  run, swim,  lift weights, hike 4-6 times per week so I took the dog for a walk thinking  fresh air and movement would help. Walked about 2 blocks and felt as if I was going to collapse and could barely walk back. Made it back, my husband turned on the gas fireplace and held me really tight until it was over. Crazy experience!
I received the second Moderna dose on  1/26/2021 at 10:10AM. No immediate reactions after the injection. At approximately, 4:47PM I noticed a small red swelling at the injection site. I took a tylenol 500MG extra strength . By 5:53PM the swelling slightly increased to the size of a dime.  On 1/27/2021, at 7:43AM  the swelling and redness had dramatically increased  larger than the size of a quarter .  By 3:49PM the swelling and redness continued to increase and get bigger to about an inch. At this point, I consulted with a doctor who advised a cream and allergy medicine.  It is 10:55PM and the swelling and redness have increased in size even more and it looks like a  large rash.  There was no itching or red lines streaming down. The shape of the rash is a  circle with dark lines and bumps on the edges.
woke up w/fever 1JUN95; fever 103.0 all day; through the noc & most of 2JUN95; woke up morning w/bumps on neck, chest & stomach;
1ST DOSE 8/24/2018 MADE ME NAUSEOUS AND WITH FLU LIKE SYMPTOMS FOR AT LEAST 3 DAYS WITH SEVERE PAIN IN THE LEFT ARM WHICH SUBSIDED IN ABOUT A WEEK. 2ND DOSE 12/28/2018 HAS RESULTED IN HAVING SEVERE PAIN IN THE LEFT ARM WHICH HAS NOT GONE AWAY. IT HAS BEEN A MONTH AND A HALF AND A I STILL HAVE SEVERE PAIN IN MY ARM THAT FEELS LIKE NERVE DAMAGE OR MUSCLE DAMAGE.
Usual soreness at injection site; Then a few days of itchy, red area on left arm; Then a few days of itchy, red area on left arm; Administered date 13Oct2021 at 11:00, dose number=3; This is a spontaneous report from a contactable consumer, the patient. An elder female patient of unspecified age received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the left arm on 13Oct2021 at 11:00 as a single dose for COVID-19 immunisation. Medical history included osteoarthritis. The patient had unspecified allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included first dose of the influenza vaccine inact sag 4v (FLUAD QUAD) in left arm on 15Sep2021 for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 09Mar2021 as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 as a single dose for COVID-19 immunisation. On 13Oct2021 at 11:00, the patient had "administration date 13Oct2021 at 11:00, dose number=3". On 14Oct2021, the patient experienced usual soreness at injection site, then a few days of itchy, red area on left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events usual soreness at injection site, then a few days of itchy, red area on left arm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events usual soreness at injection site, then a few days of itchy, red area on left arm was recovering at the time of this report. The clinical outcome of the event "administration date 13Oct2021 at 11:00, dose number=3" was unknown at the time of this report.
vesicular scattered rash on trunk with onset 13 days after varicella vaccine, no fever, mild itching. Symptomatic treatment prescribed and observation
patient started with Lupus 2 weeks after receiving Engerix-B.; This case was reported by a pharmacist via call center representative and described the occurrence of systemic lupus erythematosus in a female patient who received HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, 2 weeks after receiving Engerix B, the patient experienced systemic lupus erythematosus (serious criteria GSK medically significant). On an unknown date, the outcome of the systemic lupus erythematosus was unknown.   It was unknown if the reporter considered the systemic lupus erythematosus to be related to Engerix B.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Engerix B and experienced lupus. The physician was trying to collect as much information. No details were available from patient. The reporter did not consent to follow up. No further information available.
Allergic reaction; Hives at injection site; difficulty breathing; pain & swelling at injection site; pain & swelling at injection site; fever; nausea; fatigue; headache; Dose received: 3; This is a spontaneous report received from a non-contactable reporter (consumer). The reporter is the patient.  A 23-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 16Nov2021 10:00 (lot number: EW0185) at the age of 23-years-old as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Gastroparesis" (unspecified if ongoing); "Bipolar type 2" (unspecified if ongoing); "Chronic pain" (unspecified if ongoing); "Known allergies: Berries" (unspecified if ongoing); "Known allergies: Beef" (unspecified if ongoing); and "Known allergies: adhesive" (unspecified if ongoing). Concomitant medications included: LAMICTAL; CYMBALTA; TYLENOL; and BEN. Vaccination history included: BNT162B2 (lot number: EW0153, in left arm at dose 1, single), administration date: 10Apr2021, when the patient was 23-years-old, for COVID-19 immunization and BNT162B2 (lot number: EW0172, in left arm at dose 2, single), administration date: 01May2021, when the patient was 23-years-old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 16Nov2021 10:00, outcome "unknown", described as "Dose received: 3"; HYPERSENSITIVITY (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "Allergic reaction"; VACCINATION SITE URTICARIA (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "Hives at injection site"; DYSPNOEA (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "difficulty breathing"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 16Nov2021 10:15, outcome "recovered" (Nov2021) and all described as "pain & swelling at injection site"; PYREXIA (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "fever"; NAUSEA (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "nausea"; FATIGUE (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "fatigue"; and HEADACHE (non-serious) with onset 16Nov2021 10:15, outcome "recovered" (Nov2021), described as "headache". Therapeutic measures were taken as a result of hypersensitivity, vaccination site urticaria, and dyspnea. Additional information: The patient has no COVID prior to vaccination. There were no other vaccines in four weeks. She was not tested for COVID post vaccination. Vaccine facility type was reported as public health clinic/veterans administration facility. She took BENADRYL for hypersensitivity, vaccination site urticaria, and dyspnea.  No follow-up attempts are possible. No further information is expected.
Pt received covid vaccine series and has been hospitalized.   Per H&P   Patient:   Age: 51 Years     Sex: Female       Chief Complaint   pt reports swelling to face and neck states hist of hereditary angioedema/ took 80mg prednisone PTA  History of Present Illness        51 F with h/o hereditary angioedema since age 7 presented with neck and throat swelling, R arm swelling and feeling of tightness in her throat starting 1 day back. she is in a recovery program from cocaine and alcohol use - sober for 16 days. she took 80 mg prednisone prior to arrival.  denies other health concerns recently.  reports mother and sister have same condition.  reports had emergency tracheostomy due to angioedema at age 21. has been intubated several times in her life for this and reports has a lot of airway scar tissue.  Unknown vaccine manufacturer, dates, facility received.
-Within first day through 1 week: dry mouth, excessive thirst, thick mucus, skin sensitivity, dizziness, hyperactivity, hypervigilance, insomnia, irritability,  -Persistent even 4 weeks after vaccine: confusion, increase in autism symptoms of sensitivity, "scrambled propioception sensory symptoms", "mismatch of emotions"
Breakthrough case admission/ED/Expiration  after 2 vaccines Pfizer 3/18/21 Lot# Er2613;  Pfizer 4/8/21 Lot# Ew0150